•
Sep 30, 2023
biote Q3 2023 Earnings Report
Biote's revenue and Adjusted EBITDA grew, reflecting patient demand for hormone optimization and wellness therapies.
Key Takeaways
Biote reported an 8.5% increase in revenue to $45.6 million and a net income of $19.6 million for the third quarter of 2023. The company's Adjusted EBITDA increased by 14.7% to $14.0 million.
Revenue increased by 8.5% to $45.6 million.
Gross profit margin increased by 70 basis points to 68.9%.
Net income was $19.6 million, with earnings per share of $0.25.
Adjusted EBITDA increased by 14.7% to $14.0 million.
biote
biote
Forward Guidance
Biote anticipates that 2023 revenue and Adjusted EBITDA will likely be toward the lower end of the provided guidance range.